Skip to main content
Premium Trial:

Request an Annual Quote

GenData and Amgen Sign Drug-, Diagnostic-Development Partnership

NEW YORK, Jan. 5 (GenomeWeb News) - GenData and Amgen will partner to develop drugs and diagnostics for an undisclosed disease, GenData said today.


Under the collaboration, Amgen will select genetic targets identified by GenData's population genetics discovery platform, based on the Utah Genetic Reference Product and the Utah Population Database. The drug maker will also pay GenData for "research activities, product-development milestones," and for products developed, according to GenData.


GenData, based in Salt Lake City, provides commercial access to the Utah Population Database, which contains more than seven million records, including genealogical records, population records, and vital statistics linked to medical information.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.